JP2021535168A5 - - Google Patents

Info

Publication number
JP2021535168A5
JP2021535168A5 JP2021511593A JP2021511593A JP2021535168A5 JP 2021535168 A5 JP2021535168 A5 JP 2021535168A5 JP 2021511593 A JP2021511593 A JP 2021511593A JP 2021511593 A JP2021511593 A JP 2021511593A JP 2021535168 A5 JP2021535168 A5 JP 2021535168A5
Authority
JP
Japan
Prior art keywords
composition
subject
sequence
virus
nucleic acid
Prior art date
Application number
JP2021511593A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020047368A5 (https=
JP7587275B2 (ja
JP2021535168A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/048985 external-priority patent/WO2020047368A1/en
Publication of JP2021535168A publication Critical patent/JP2021535168A/ja
Publication of JPWO2020047368A5 publication Critical patent/JPWO2020047368A5/ja
Publication of JP2021535168A5 publication Critical patent/JP2021535168A5/ja
Priority to JP2024091954A priority Critical patent/JP7807105B2/ja
Application granted granted Critical
Publication of JP7587275B2 publication Critical patent/JP7587275B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021511593A 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法 Active JP7587275B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024091954A JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862724780P 2018-08-30 2018-08-30
US62/724,780 2018-08-30
PCT/US2019/048985 WO2020047368A1 (en) 2018-08-30 2019-08-30 Methods of treating or preventing amyotrophic lateral sclerosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024091954A Division JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Publications (4)

Publication Number Publication Date
JP2021535168A JP2021535168A (ja) 2021-12-16
JPWO2020047368A5 JPWO2020047368A5 (https=) 2022-06-13
JP2021535168A5 true JP2021535168A5 (https=) 2022-06-13
JP7587275B2 JP7587275B2 (ja) 2024-11-20

Family

ID=69643060

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021511593A Active JP7587275B2 (ja) 2018-08-30 2019-08-30 筋萎縮性側索硬化症の治療方法または予防方法
JP2024091954A Active JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024091954A Active JP7807105B2 (ja) 2018-08-30 2024-06-06 筋萎縮性側索硬化症の治療方法または予防方法

Country Status (9)

Country Link
US (2) US12508327B2 (https=)
EP (1) EP3844285A4 (https=)
JP (2) JP7587275B2 (https=)
KR (1) KR20210053305A (https=)
CN (1) CN112673107A (https=)
AU (2) AU2019328337B2 (https=)
CA (1) CA3107612A1 (https=)
IL (1) IL280965B2 (https=)
WO (1) WO2020047368A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3844285A4 (en) * 2018-08-30 2022-06-29 Rowan University Methods of treating or preventing amyotrophic lateral sclerosis
WO2025240562A1 (en) * 2024-05-15 2025-11-20 Woolsey Pharmaceuticals, Inc. Method of treating amyotrophic lateral sclerosis with trimetazidine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2753379B1 (fr) * 1996-09-13 1998-10-30 Rhone Poulenc Rorer Sa Methode de traitement de la sclerose laterale amyotrophique
FR2923962B1 (fr) 2007-11-20 2009-11-20 Valeo Sys Controle Moteur Sas Circuit elevateur de tension
EP2826860B1 (en) * 2010-04-23 2018-08-22 University of Massachusetts CNS targeting AAV vectors and methods of use thereof
EP3778887B1 (en) * 2012-05-30 2025-07-09 Rowan University Nucleic acid encoding aspa for use in the treatment of parkinson's disease
US11413356B2 (en) 2016-04-15 2022-08-16 University Of Massachusetts Methods and compositions for treating metabolic imbalance
EP3844285A4 (en) 2018-08-30 2022-06-29 Rowan University Methods of treating or preventing amyotrophic lateral sclerosis

Similar Documents

Publication Publication Date Title
US20240398909A1 (en) Secreted splicing variant of mammal klotho as a medicament for cognition and behaviour impairments
JP2024133479A5 (https=)
JP2020518259A5 (https=)
RU2019103488A (ru) Способы и композиции для лечения нарушений и заболеваний, связанных с rdh12
WO2009052737A1 (en) Medicament for preventing and controlling alzheimer's disease
JP2019524090A5 (https=)
US20250099554A1 (en) Compositions and methods of fas inhibition
JP7759174B2 (ja) 繊毛病のための遺伝子治療
JP2021533126A (ja) 臓器機能を制御するための遺伝子治療方法
JP2021535168A5 (https=)
US20220378942A1 (en) Compositions and methods for treating alzheimer's disease
US10639351B2 (en) Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
JPWO2020047368A5 (https=)
CN121057823A (zh) 体内修饰神经元以治疗和/或预防肌萎缩性侧索硬化(als)的方法
JPWO2022046988A5 (https=)
US20220136005A1 (en) One-step gene therapy for duchenne muscular dystrophy via gene replacement and anti-inflammation
EP3436078B1 (en) Methods and compositions for the treatment of als
US20200297868A1 (en) Methods and compositions for the treatment of als
Landhuis The gene fix
US20230279434A1 (en) Methods and compositions for the treatment of als
JPWO2021155337A5 (https=)
CN118909979A (zh) 一种重组腺相关病毒AAV-Lec及其制备方法和应用
WO2018069422A1 (en) Methods and pharmaceutical compositions for the treatment of non-alcoholic fatty liver disease
Koprich et al. MOLECULAR NEURODEGENERATION.
JPWO2021183779A5 (https=)